← Back to Search

Mental Health Support for HIV (CHIMES Trial)

N/A

Waitlist Available

Led By Sophia Hussen, MD, MPH

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (months 1-12) up to month 33

Awards & highlights

No Placebo-Only Group

Summary

This trial will test an intervention to improve YB-GBMSM's engagement in HIV and mental health care at Ryan White clinics.

Who is the study for?

This trial is for young Black gay, bisexual, and other men who have sex with men (YB-GBMSM) living with HIV. Participants must be patients at Grady Health System Infectious Disease Program or Emory University Hospital Midtown Infectious Disease Clinic.

What is being tested?

The study is testing a new support intervention called CHIMES against the standard care provided in clinics. The goal is to improve how these young men engage with their HIV and mental health treatments.

What are the potential side effects?

Since this trial focuses on a support intervention rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological responses to the intervention.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (months 1-12) up to month 33

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (months 1-12) up to month 33

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (months 1-12) up to month 33 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of Mental Health Care Referrals

Number of Mental Health Visits

Number of Patients Attending Two HIV Care Visits

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Clinic Patients During the Maintenance PeriodExperimental Treatment1 Intervention

Patients visiting one of the study clinics during the Maintenance period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 28 - 33.

Group II: Clinic Patients During the Implementation PeriodExperimental Treatment1 Intervention

Patients visiting one of the study clinics during the Implementation period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 13 - 27.

Group III: Clinic Patients During the Pre-implementation PeriodActive Control1 Intervention

Patients visiting one of the study clinics prior to implementation of the CHIMES intervention. The Baseline time period consists of study Months 1 - 12. Data are retroactively abstracted from medical records of patients who had clinic visits that occurred between January 1, 2019 and December 31, 2019.

Do I qualify?Apply below to find out